Key result
Surgical septal myectomy has evolved into the gold standard therapy for symptomatic obstructive hypertrophic cardiomyopathy, achieving mortality under 1% and symptom relief in over 90% of patients.
This historical review reinforces surgical septal myectomy as the gold standard for relieving LVOT obstruction in HCM and details the evolution of operative techniques to address complex septal anatomies.
Our understanding of hypertrophic cardiomyopathy (HCM) as a disease entity has increased dramatically over the last half century. There has been a concerted effort by several surgical groups to develop operative techniques to relieve left ventricular outflow tract (LVOT) obstruction and alleviate symptoms. This paper traces the development of transaortic septal myectomy, the current gold standard therapy for relief of LVOT obstruction, in symptomatic patients refractory to medical treatment. In addition, we introduce newer methods for myectomy that have expanded the role of surgery in patients with various forms of HCM.
No takes yet. Share an insight, caveat, or question.
Hang et al. (2017) conducted a review in Hypertrophic cardiomyopathy (HCM). Surgical septal myectomy was evaluated. Surgical septal myectomy has evolved into the gold standard therapy for symptomatic obstructive hypertrophic cardiomyopathy, achieving mortality under 1% and symptom relief in over 90% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: